Weight Management
Compounded Tirzepatide
Injection + NAD+ · B-12 · L-Carnitine
Tirzepatide is the most advanced GLP-1 weight loss therapy available — acting on both GLP-1 and GIP receptors for dual appetite suppression and metabolic regulation. Clinical trials demonstrate an average of ~20% total body weight loss, making it the most effective anti-obesity medication on the market.
Clinician review required. Prescription issued by board-certified provider.
Everything Included at $339/month
No hidden fees. No surprises. Cancel anytime.
Personalized Titration Schedule
Your dose is increased gradually to minimize side effects and maximize results. Your clinician adjusts your protocol based on your individual response.
How It Works
From intake to treatment in as little as 24 hours.
Complete Health Intake
Answer a short HIPAA-secure questionnaire about your health history, weight goals, and any medications.
Clinician Review & Rx
A board-certified provider reviews your intake and, if appropriate, prescribes compounded tirzepatide with a personalized dosing schedule.
Medication Delivered
Your injectable tirzepatide is shipped to your door from a licensed 503A compounding pharmacy, temperature-controlled.
Ongoing Care & Adjustments
Your provider monitors your progress, adjusts doses as needed, and supports you every step of the way.
Frequently Asked Questions
Ready to Start Your Journey?
Join thousands of patients achieving their health goals with clinician-guided, evidence-based tirzepatide therapy.
Month-to-month · Cancel anytime · Clinician review required · Rx by board-certified provider
What You Need to Know
What is compounded tirzepatide?
Compounded tirzepatide is a once-weekly injectable medication that mimics two gut hormones — GLP-1 and GIP — to reduce appetite, slow stomach emptying, and improve blood sugar control. It is prescribed by licensed clinicians and prepared by state-licensed compounding pharmacies for patients who meet clinical criteria.
- Dual GLP-1 + GIP receptor agonist for dual-pathway appetite control
- Once-weekly subcutaneous injection with B12
- Titration from 2.5 mg up to 10–15 mg maintenance
- Average ~20–22% weight loss over 72 weeks in clinical trials
Side by Side
Semaglutide vs Tirzepatide
Both are GLP-1 weight-loss medications. Here's how they compare so you can choose with your clinician.
| Compare | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1 + GIP agonist |
| Dosing | Weekly injection or daily sublingual | Once-weekly injection |
| Avg. Weight Loss | ~15% over 68 weeks | ~20–22% over 72 weeks |
| Starting Price | $239/mo (injection w/ B12) | $339/mo (injection w/ B12) |
| Best For | Steady, well-tolerated loss | Higher average loss, dual pathway |